Drug profile · INN
lopinavir
KALETRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lopinavir (KALETRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN lopinavir
Brand KALETRA
Route ORAL
Formulation CAPSULE
ATC code J05AR10
Frequently asked questions
What is lopinavir?
lopinavir (KALETRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lopinavir?
KALETRA is a marketed brand name for lopinavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lopinavir?
lopinavir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.